Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The partnership is expected to yield treatments that demonstrate efficacy and offer improved quality of life and tolerability ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

After being diagnosed with breast cancer in 2022, Amy Carswell had a ‘difficult experience’, but she has ‘come out the other ...

Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.